Searched for
ROBERT COURY
Biocon Biologics acquires Viatris' biosimilar business for $3.34 billionBBL said the cash payment of $2 billion to be funded by $800 million raised through equity infusion in BBL and the remainder to be funded b...28 Feb, 2022, 07.50 AM IST- Mylan fails in $26 bn bid to buy fellow drugmaker PerrigoMylan NV's $26 bn hostile bid for Perrigo collapsed on Friday after the Netherlands-based drugmaker failed to secure at least half of Perri...13 Nov, 2015, 09.50 PM IST
- Mylan rejects Teva's $40 billion merger offer as undervaluedDrug major Mylan has rejected a $40 billion unsolicited merger offer from Israel's Teva Pharmaceutical Industries calling the bid undervalu...28 Apr, 2015, 03.25 PM IST
- Agila, with first class people, is a very high-quality asset: Rajiv MalikMylan has completed the acquisition of Agila Specialties division from Strides Arcolab for a total value of $1.75 billion (about Rs10,800 c...07 Dec, 2013, 04.41 AM IST
- Matrix weighs Docpharma saleHyderabad-based Matrix Labs, in which US-based Mylan Labs holds a controlling stake, is toning up its business focus.29 Feb, 2008, 12.04 AM IST
- US pharma major Mylan buys Matrix LabsThe generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.29 Aug, 2006, 01.58 AM IST
Load More
